NCT00766259

Brief Summary

Inpatients will be prospectively have nares screened and MRSA strains collected. All clinical MRSA strains of patients will also be prospectively collected. A sensitive strain discrimination test of spa typing will be used to determine if the strains are related. Hypotheses are

  1. 1.Strain colonization durations vary and may be very short in days to weeks.
  2. 2.Colonizing strains rarely infect 3) Both 1 and 2 may be affected by the patient's co-morbidity.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2009

Typical duration for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 3, 2008

Completed
9 months until next milestone

Study Start

First participant enrolled

July 1, 2009

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

May 3, 2024

Status Verified

March 1, 2021

Enrollment Period

1.9 years

First QC Date

October 2, 2008

Last Update Submit

May 1, 2024

Conditions

Keywords

methicillin-resistant Staphylococcuscolonization

Outcome Measures

Primary Outcomes (1)

  • Percent of infection strains which were also colonizer earlier

    3 years

Secondary Outcomes (1)

  • Duration of strain colonization among co-morbidity cohorts

    3 years

Study Arms (6)

1

Hemodialysis

2

Intensive care

3

vascular patients with open wounds

4

nursing home

5

skin infections

6

control- ambulatory care clinic patients with no infections

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all patients admited

You may qualify if:

  • Admitted and one of the co-morbid groups
  • Ambulatory care patient with no infections

You may not qualify if:

  • All others

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: NONE RETAINED

only bacterial strains collected

0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2008

First Posted

October 3, 2008

Study Start

July 1, 2009

Primary Completion

June 1, 2011

Study Completion

June 1, 2012

Last Updated

May 3, 2024

Record last verified: 2021-03